on 11 Oct 2022
Last Applicant/ Owned by
4505 Emperor Blvd., Suite 300
Durham
NC
27703
Serial Number
88831981 filed on 12th Mar 2020
Registration Number
6873191 registered on 11th Oct 2022
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Pharmaceutical preparations and substances for the treatment and/or prevention of fungal and parasitic infections; Pharmaceutical preparations and substances for the prevention and/or treatment of mucosal, invasive, and superficial fungal infections, including those caused by candida and dermatophyte species; Pharmaceutical preparations and substances for the prevention and/or treatment of endemic Read More
Pharmaceutical preparations and substances for the treatment and/or prevention of fungal and parasitic infections; Pharmaceutical preparations and substances for the prevention and/or treatment of mucosal, invasive, and superficial fungal infections, including those caused by candida and dermatophyte species; Pharmaceutical preparations and substances for the prevention and/or treatment of endemic fungal diseases or infections; Pharmaceutical preparations for the treatment and prevention of skin conditions; Pharmaceutical preparations, namely, gels, creams, sprays or other topical preparations treatment of skin conditions; Intravenous pharmaceutical preparations for the treatment and prevention of invasive fungal infections
18th Jul 2022
18th Jul 2022
No 88831981
No Service/Collective Mark
No 029850.018
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
11th Oct 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
11th Oct 2022 | REGISTERED-PRINCIPAL REGISTER |
08th Sep 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
07th Sep 2022 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
02th Aug 2022 | STATEMENT OF USE PROCESSING COMPLETE |
02th Aug 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
18th Jul 2022 | USE AMENDMENT FILED |
18th Jul 2022 | TEAS STATEMENT OF USE RECEIVED |
11th Feb 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
09th Feb 2022 | SOU EXTENSION 3 GRANTED |